<address id="3xt9h"></address>
Explore the latest in diabetes and endocrinology, including advances in the diagnosis and management of diabetes, thyroid disorders, and more.
This Medical Letter compares a newly approved fixed-dose combination pill comprising the sodium-glucose cotransporter 2 inhibitor empagliflozin, the dipeptidyl peptidase-4 inhibitor linagliptin, and extended-release metformin, with available formulations of each of the pill’s individual components for oral treatment of type 2 diabetes in adults.
This randomized clinical trial compares the diagnostic performance between an RNA test and a DNA-RNA test in patients with thyroid nodules.
A 63-year-old woman with type 2 diabetes was referred for refractory hypomagnesemia (1.4 mg/dL; low normal, 1.8 mg/dL). Her medications included liraglutide, metformin, lisinopril, and magnesium oxide (400 mg twice daily). A recent hemoglobin A1c level was 10.8%, and her urinary magnesium was 117 mg. How do you interpret the urine level, and what would you do next?
This cohort study examines the mechanisms, risk factors, and outcomes associated with acute kidney injury during pediatric diabetic ketoacidosis.
This case report describes a case of compressive optic neuropathy in thyroid eye disease that was sucessfully resolved with teprotumumab.
This study examines cost sharing for novel second-line diabetes treatment agents under Medicare Part D.
This narrative review assesses the evaluation and treatment of patients with hypercortisolism.
This cross-sectional study evaluates the association of the distribution of diabetic retinopathy lesions with optical coherence tomography angiography (OCTA) metrics and the severity of diabetic retinopathy.
This cohort study evaluates the association of heart failure and ischemic heart disease with diabetes complications.
This cohort study examines the use of ultrasonography in an active surveillance program to suggest continued surveillance vs surgery in patients with low-risk papillary thyroid cancer.
This ancillary study of a randomized clinical trial examines the long-term associations of an intensive lifestyle intervention for type 2 diabetes with health care use, spending, and disability.
This cohort study characterizes the relative association of conventional and novel biomarkers in Mediterranean diet–related type 2 diabetes risk reduction in a US population.
This meta-analysis compares surgical outcomes with and without use of intraoperative parathyroid hormone during minimally invasive parathyroidectomy.
This cross-sectional study evaluates the use of machine learning for prediction of congenital adrenal hyperplasia based on distinct facial morphologic features.
This randomized clinical trial assesses the efficacy of α-cyclodextrin for cholesterol control and that of hydrolyzed ginseng for glycemic control in people with prediabetes and overweight or obesity.
This subgroup analysis of 2 cluster randomized clinical trials examines adults presenting to the emergency department with diabetic ketoacidosis and determines how long it takes to reach resolution by treating with balanced crystalloids vs saline.
This cohort study evaluates candidacy for initiation of dapagliflozin based on the US Food and Drug Administration label among contemporary US patients with heart failure with reduced ejection fraction and describes potential barriers to therapeutic optimizations.
This cross-sectional study evaluates which health indicators have improved or worsened among Black and Hispanic middle-aged and older adults since the Minority Health and Health Disparities Research and Education Act of 2000.
This case report describes an adolescent male with a history of prediabetes and obesity who presented with a diagnosis of confluent and reticulated papillomatosis with features of acanthosis nigricans.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: